A post hoc analysis of three clinical trials of tenapanor (Ibsrela, Ardelyx) shows the drug works within weeks to improve bowel function and abdominal symptoms in people with irritable bowel syndrome with constipation (IBS-C). “Although onset of action occurs within the first week, continued therapy allows for a greater percentage of patients to achieve a...